4//SEC Filing
SIDES TERI WOODWICK 4
Accession 0001193125-25-288446
CIK 0000924717other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:14 PM ET
Size
22.5 KB
Accession
0001193125-25-288446
Insider Transaction Report
Form 4
SURMODICS INCSRDX
SIDES TERI WOODWICK
SVP, Vascular Interventions
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2025-11-19−18,337→ 0 totalExercise: $43.93Exp: 2028-11-30→ Common Stock (18,337 underlying) - Disposition to Issuer
Common Stock
2025-11-19−34,703→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2025-11-19−28,864→ 0 totalExercise: $36.13Exp: 2029-11-30→ Common Stock (28,864 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-11-19−29,582→ 0 totalExercise: $33.64Exp: 2030-12-04→ Common Stock (29,582 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-11-19−12,292→ 0 totalExercise: $56.63Exp: 2025-11-27→ Common Stock (12,292 underlying) - Disposition to Issuer
Employee Stock Options (right to buy)
2025-11-19−17,883→ 0 totalExercise: $37.44Exp: 2027-11-30→ Common Stock (17,883 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-11-19−5,463→ 0 totalExercise: $56.63Exp: 2025-11-27→ Common Stock (5,463 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-11-19−8,356→ 0 totalExercise: $42.00Exp: 2026-11-25→ Common Stock (8,356 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2025-11-19−15,668→ 0 totalExercise: $42.00Exp: 2026-11-25→ Common Stock (15,668 underlying)
Footnotes (3)
- [F1]Pursuant to that certain Merger Agreement, dated as of May 28, 2024, by and among the Surmodics, Inc. (the "Issuer"), BCE Parent, LLC, ("Parent"), and BCE Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.05 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $43.00 per share in cash, without interest and subject to any applicable tax withholdings (the "Merger Consideration"). All outstanding restricted stock units ("RSUs") held by the reporting person vested immediately prior to the Effective Time and the reporting person is entitled to receive the Merger Consideration for such vested RSUs.
- [F2]As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Common Stock.
- [F3]Pursuant to the Merger Agreement, at the Effective Time, this unexercised stock option ("Option") was cancelled and automatically converted into the right to receive an amount in cash (without interest) equal to the product of (a) the aggregate number of shares of Common Stock subject to the Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over such Option's applicable per share exercise price, subject to any required tax withholdings.
Documents
Issuer
SURMODICS INC
CIK 0000924717
Entity typeother
Related Parties
1- filerCIK 0001758749
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:14 PM ET
- Size
- 22.5 KB